Literature DB >> 2392906

Regional glycosaminoglycans composition of the human sclera.

K Trier1, E B Olsen, T Ammitzbøll.   

Abstract

Human sclera from different parts of the normal adult eye was analyzed for content of uronic acid and the distribution of specific glycosaminoglycan types. Uronic acid is widely determined as representative of glycosaminoglycans in biological substances and variations of about 2-fold were found. Differences of up to 50% were detected in the relative abundance of hyaluronic acid and of dermatan sulphate, depending on the site on the globe from which the sample was taken. Sclera from around the papilla was found to be rich in content of dermatan sulphate. Sclera from the posterior eyeball showed a higher percentage of chondroitin sulphate as compared with sclera from equator and limbus. Equatorial sclera was richer in hyaluronic acid than posterior sclera. Sclera from the posterior eyeball showed a higher content of uronic acid as compared with sclera from equator and limbus. This work is an addition to the understanding of the scleral biochemistry and this finding may have some relevance in connection with ocular disease, as the proteoglycans and their content of glycosaminoglycans play a key role in the regulation of collagen fibril assembly and in the biomechanical strength of collagen fibrils.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2392906     DOI: 10.1111/j.1755-3768.1990.tb01926.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  10 in total

1.  Cloning and characterization of cell strains derived from human corneal stroma and sclera.

Authors:  Yoshiko Kashiwagi; Koichi Nishitsuka; Hiroyuki Namba; Masaru Kamiryo; Hiroshi Takamura; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

2.  The contribution of glycosaminoglycans to the mechanical behaviour of the posterior human sclera.

Authors:  Barbara J Murienne; Michelle L Chen; Harry A Quigley; Thao D Nguyen
Journal:  J R Soc Interface       Date:  2016-06       Impact factor: 4.118

3.  Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, or L-ornithine.

Authors:  K Trier; E B Olsen; T Kobayashi; S M Ribel-Madsen
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

4.  Enhancement of scleral macromolecular permeability with prostaglandins.

Authors:  R N Weinreb
Journal:  Trans Am Ophthalmol Soc       Date:  2001

5.  The effects of glycosaminoglycan degradation on the mechanical behavior of the posterior porcine sclera.

Authors:  Barbara J Murienne; Joan L Jefferys; Harry A Quigley; Thao D Nguyen
Journal:  Acta Biomater       Date:  2014-11-04       Impact factor: 8.947

6.  Modulation of glycosaminoglycan levels in tree shrew sclera during lens-induced myopia development and recovery.

Authors:  Anisha G Moring; John R Baker; Thomas T Norton
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

7.  Dasatinib inhibits peripapillary scleral myofibroblast differentiation.

Authors:  Amanda Chow; Liam McCrea; Elizabeth Kimball; Julie Schaub; Harry Quigley; Ian Pitha
Journal:  Exp Eye Res       Date:  2020-03-13       Impact factor: 3.467

8.  Glaucoma-related Changes in the Mechanical Properties and Collagen Micro-architecture of the Human Sclera.

Authors:  Baptiste Coudrillier; Jacek K Pijanka; Joan L Jefferys; Adhiraj Goel; Harry A Quigley; Craig Boote; Thao D Nguyen
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

9.  Regional Differences in the Glycosaminoglycan Role in Porcine Scleral Hydration and Mechanical Behavior.

Authors:  Mohammad Pachenari; Hamed Hatami-Marbini
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

10.  RNA sequencing analysis of long non-coding RNA expression in ocular posterior poles of guinea pig myopia models.

Authors:  Chao Geng; Yahong Li; Fang Guo; Jindan Wang; Yiyun Yue; Kewen Zhou; Ruihua Wei; Yan Zhang
Journal:  Mol Vis       Date:  2020-03-05       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.